ALDEYRA THERAPEUTICS, INC. 8-K

Company

Aldeyra Therapeutics, Inc.

Filed

June 27, 2023

Period of Report

June 27, 2023

Accession Number

0001157523-23-001035

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →